| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $436.7M | +9.8% |
| R&D Expense | $30.6M | +22.7% |
| SG&A Expense | $117.7M | +4.6% |
| Operating Income | -$184.3M | -632.7% |
| Pre-tax Income | -$199.3M | — |
| Income Tax | $2.0M | +107.7% |
| Net Income | -$201.0M | -913.2% |
| EPS (Basic) | -$1.45 | — |
| EPS (Diluted) | -$1.45 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.8M | -30.0% |
| Accounts Receivable | $116.5M | -18.5% |
| Current Assets | $198.6M | -21.1% |
| Total Assets | $530.0M | -16.8% |
| Current Liabilities | $122.9M | +30.5% |
| Long-term Debt | $152.3M | +7.3% |
| Total Liabilities | $335.4M | +27.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.9M | -1085.8% |
| Capital Expenditures | $5.4M | +8.9% |
| Investing Cash Flow | -$17.3M | +91.7% |
| Financing Cash Flow | $3.2M | -98.3% |
| Free Cash Flow | -$13.3M | -217.3% |
| -4733.3% |
| Stockholders' Equity |
| $191.2M |
| -48.4% |